Corrigendum: CRISPR-Cas9 mediated efficient PD-1 disruption on human primary T cells from cancer patients

Detalles Bibliográficos
Autores principales: Su, Shu, Hu, Bian, Shao, Jie, Shen, Bin, Du, Juan, Du, Yinan, Zhou, Jiankui, Yu, Lixia, Zhang, Lianru, Chen, Fangjun, Sha, Huizi, Cheng, Lei, Meng, Fanyan, Zou, Zhengyun, Huang, Xingxu, Liu, Baorui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2017
Materias:
Corrigenda
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5244626/
https://www.ncbi.nlm.nih.gov/pubmed/28102301
http://dx.doi.org/10.1038/srep40272

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5244626/
https://www.ncbi.nlm.nih.gov/pubmed/28102301
http://dx.doi.org/10.1038/srep40272

Ejemplares similares